P7C3-A20 is primarily investigated for its neuroprotective properties. It enhances the survival of newborn neurons in the brain, making it a compound of interest in the treatment of neurodegenerative diseases such as Parkinson’s and Alzheimer’s. Studies show it can improve cognitive function and reduce neuronal cell death in animal models of brain injury and aging. It has also demonstrated potential in protecting against chemotherapy-induced neuropathy and promoting recovery after traumatic brain injury. Due to its ability to cross the blood-brain barrier effectively, it is considered a promising candidate for central nervous system therapeutics. Research is ongoing to explore its use in mood disorders and other conditions involving neuronal damage.